1
Name
1 Name
This instrument is the Health Insurance (Diagnostic Imaging Accreditation – Approved Accreditors) Instrument 2020.
//
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Commonwealth legislation
This instrument, commencing 1 April 2020, names three specific organisations as approved accreditors under the diagnostic imaging accreditation scheme established under the Health Insurance Act 1973. It affects diagnostic imaging practices and the named accrediting bodies by determining who is authorised to carry out accreditation (s6). It does not set accreditation standards itself; it operates by listing approved accreditors and by amending instruments specified in its Schedules (s5).
Want the full deep dive?
Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.
Direct links to the current provisions in Health Insurance (Diagnostic Imaging Accreditation – Approved Accreditors) Instrument 2020.
This instrument is the Health Insurance (Diagnostic Imaging Accreditation – Approved Accreditors) Instrument 2020.
This instrument commences on 1 April 2020.
This instrument is made under section 23DZZIAA(1) of the Health Insurance Act 1973.
Note A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:
Note: a) base for mobile diagnostic imaging equipment;
Note: b) diagnostic imaging accreditation scheme;
c) diagnostic imaging premises.
In this instrument:
Act means the Health Insurance Act 1973.
diagnostic imaging practice means diagnostic imaging premises or a base for mobile diagnostic imaging equipment.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
For the purposes of paragraph 23DZZIAA(1)(b) of the Act the persons approved to accredit diagnostic imaging practices under the diagnostic imaging accreditation scheme established by the Health Insurance (Diagnostic Imaging Accreditation) Instrument 2020 are:
(a) HDAA Australia Pty Ltd (ACN 134 482 625);
(b) National Association of Testing Authorities Australia (ACN 004 379 748); and
(c) Quality Innovation Performance International Pty Ltd (ACN 094 965 590).
Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.
This instrument is the Health Insurance (Diagnostic Imaging Accreditation – Approved Accreditors) Instrument 2020.
This instrument commences on 1 April 2020.
This instrument is made under section 23DZZIAA(1) of the Health Insurance Act 1973.
Note A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:
Note: a) base for mobile diagnostic imaging equipment;
Note: b) diagnostic imaging accreditation scheme;
c) diagnostic imaging premises.
In this instrument:
Act means the Health Insurance Act 1973.
diagnostic imaging practice means diagnostic imaging premises or a base for mobile diagnostic imaging equipment.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
For the purposes of paragraph 23DZZIAA(1)(b) of the Act the persons approved to accredit diagnostic imaging practices under the diagnostic imaging accreditation scheme established by the Health Insurance (Diagnostic Imaging Accreditation) Instrument 2020 are:
(a) HDAA Australia Pty Ltd (ACN 134 482 625);
(b) National Association of Testing Authorities Australia (ACN 004 379 748); and
(c) Quality Innovation Performance International Pty Ltd (ACN 094 965 590).